Stonegate Capital Partners Updates Coverage on GoHealth Inc. (GOCO) 2025 Q3

Rhea-AI Summary

GoHealth (NASDAQ: GOCO) reported a challenging 3Q25 with net revenues of $34.2M, down ~71.0% y/y as the company intentionally pulled back Medicare Advantage volume and experienced reduced non-agency activity.

Other revenue grew as GoHealth Protect scaled. Results were depressed by significant non-cash impairment charges, while management emphasized liquidity preservation, platform efficiency, retention-first actions, and disciplined execution through the 2025 AEP. Liquidity at quarter end was $32.1M and strategic flexibility improved via a superpriority term loan and covenant relief.

Positive

• Net revenues included growth in GoHealth Protect offerings
• Quarter-end cash of $32.1M
• Strategic flexibility via superpriority term loan and covenant relief

Negative

• Net revenues declined to $34.2M (≈71% y/y)
• Meaningful declines in Medicare agency and non-agency revenues
• Significant non-cash impairment charges pressured margins

News Market Reaction

-4.54%

5 alerts

-4.54% News Effect

-34.2% Trough in 19 hr 16 min

-$3M Valuation Impact

$69M Market Cap

1.4x Rel. Volume

On the day this news was published, GOCO declined 4.54%, reflecting a moderate negative market reaction. Argus tracked a trough of -34.2% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $3M from the company's valuation, bringing the market cap to $69M at that time.

Data tracked by StockTitan Argus on the day of publication.

Dallas, Texas--(Newsfile Corp. - November 17, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. reported a difficult 3Q25 as the Company continued to navigate a materially different Medicare Advantage environment. Net revenues declined to $34.2M from $118.3M a year ago, reflecting an intentional pullback in Medicare Advantage volume, reduced non-agency activity, and a broader industry shift toward margin integrity and renewal stability. Medicare agency and non-agency revenues both declined meaningfully year over year, while other revenue increased as GoHealth Protect and related offerings continued to scale and diversify the top line. Results were further pressured by significant non-cash impairment charges, which weighed on reported margins, even as management focused on preserving liquidity, platform efficiency, and a high-quality member base. As 2025 progresses, management remains focused on retention, quality, and disciplined execution through the current AEP, with an eye toward re-accelerating when market conditions stabilize.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• In 3Q25, net revenues were $34.2M, down ~71.0% y/y, reflecting an intentional Medicare Advantage pullback and mix shift.
• As of quarter end, management highlighted a retention first focus leadership in Special Needs Plans and preserved agent tech and retention ops.
• Liquidity was $32.1M in cash and strategic flexibility improved with a superpriority term loan and covenant relief.

Click image above to view full announcement.

---

About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274792

FAQ

What were GoHealth (GOCO) revenues in 3Q25 and how big was the decline?

GoHealth reported $34.2M in 3Q25 net revenues, down approximately 71.0% year-over-year.

How much cash did GoHealth (GOCO) report at the end of 3Q25?

GoHealth reported $32.1M in cash at quarter end.

Why did GoHealth (GOCO) revenues fall sharply in 3Q25?

Management cited an intentional pullback in Medicare Advantage volume and reduced non-agency activity.

Did GoHealth (GOCO) take any financing actions in 3Q25 to improve flexibility?

Yes — the company improved strategic flexibility with a superpriority term loan and received covenant relief.

What impact did impairments have on GoHealth (GOCO) 3Q25 results?

Significant non-cash impairment charges weighed on reported margins in 3Q25.

Is GoHealth (GOCO) growing other revenue streams in 2025?

Yes — other revenue increased as GoHealth Protect and related offerings continued to scale.